Are you Dr. Bush?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 79 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
415 Ray C Hunt Dr
Charlottesville, VA 22903Phone+1 434-924-1825Fax+1 434-924-9616
Summary
- Dr. Zachary Bush, MD is an endocrinologist in Charlottesville, Virginia. He is currently licensed to practice medicine in Virginia.
Education & Training
- University of Virginia Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2009
- University of Virginia Medical CenterResidency, Internal Medicine, 2002 - 2006
- University of Colorado School of Medicine Anschutz Medical CampusClass of 2002
Certifications & Licensure
- VA State Medical License 2005 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2011-2013
Clinical Trials
- Preoperative Bexarotene Treatment for Cushing's Disease Start of enrollment: 2008 Nov 01
Publications & Presentations
PubMed
- 113 citationsTemozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expre...Zachary M. Bush, Janina A. Longtine, Tracy Cunningham, David Schiff, John A. Jane
The Journal of Clinical Endocrinology and Metabolism. 2010-11-01 - 8 citationsImmunohistochemistry of COUP-TFI: an adjuvant diagnostic tool for the identification of corticotroph microadenomas.Zachary M. Bush, Maria-Beatriz S. Lopes, Isa M. Hussaini, John A. Jane, Edward R. Laws
Pituitary. 2010-01-01 - 22 citationsManagement of acromegaly: is there a role for primary medical therapy?Zachary M. Bush, Mary Lee Vance
Reviews in Endocrine & Metabolic Disorders. 2008-03-01
Press Mentions
- Transcript of Episode 177: Eliminating Pain with Posture TherapyJuly 14th, 2017
Grant Support
- Retinoic Acid Receptors: A Novel Therapeutic Target For Cushing'S DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009